WELCOME TO The HEALTHCARE REPORT
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Humana, NQF | April 22, 2020
The COVID-19 pandemic is putting a spotlight on why it’s critical for population-based models to consider the impacts of patients’ social needs, experts say. William Shrank, M.D., chief medical officer at Humana, and Shantanu Agrawal, M.D., CEO of the National Quality Forum, co-authored an analysis this week that argues social risks should be weighed alongside clinical risks in population-based payment models. Shrank said that the coronavirus pandemic is further highlighting the impa...
Cision PR Newswire | July 29, 2020
Unlocking value from the data scattered across healthcare communities was once a tantalizing opportunity. After COVID-19, it is an existential necessity. Chilmark Research's latest Market Trends Report, Open APIs in Healthcare: The Future of Data Integration, captures a market whose approach to data access and integration will be changing substantially in the coming years and introduces a subvertical within healthcare IT that anticipates a 16% CAGR through 2025.Outside healthcare, the ascend...
Honest Medical Group | June 13, 2022
MedNetOne Health Solutions announced it is the first Michigan physician organization to enter into a joint venture with Nashville-based Honest Medical Group, a physician enablement company aimed at improving the health care experience and reducing costs for members with Medicare Advantage.
The announcement was made by MedNetOne co-founders Ewa Matuszewski, CEO, and Al Juocys, D.O., President and Chief Medical Officer. It follows Blue Cross Blue Shield of Michigan's announcement ...
Revibe technologies | February 09, 2022
Revibe technologies, a commercial-stage digital therapeutics company, announced today the positive results of their feasibility study examining the efficacy of FokusRx in school aged children with attention deficit hyperactivity disorder (ADHD). FokusRx is an investigational SaMD (Software as a Medical Device) that has the potential to provide a new nonpharmacologic approach to treating attention, focus and hyperactivity deficits associated with ADHD, and other mental health conditions.
FUTURE OF HEALTHCARE
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE